BlackRock Fund Advisors recently announced the acquisition of new stake in Genprex Inc. (NASDAQ:GNPX). This fresh investment now brings its stake to 4.26% valued currently at $5.55 million. In addition, SSgA Funds Management, Inc. raised its holdings by 0.43 million to 0.43 million shares. And The Vanguard Group, Inc. has lifted its position by 29.67% or 87136.0 shares – to 0.38 million shares.
With over 2.34 million Genprex Inc. (GNPX) shares trading Monday and a closing price of $3.93 on the day, the dollar volume was approximately $9.2 million. The shares have shown a negative weekly performance of -1.26% and its price on 08/24/20 gained nearly 3.42%. Currently, there are 35.36M common shares owned by the public and among those 31.32M shares have been available to trade.
Incidentally, analysts’ outlook for the Genprex Inc. stock is 2.00 for the next 12 months.
Insiders at the company have transacted a total of 1 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 1 of these insider trades were purchases, accounting for 1,800 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The top 3 mutual fund holders in Genprex Inc. are iShares Russell 2000 ETF, Vanguard Extended Market Index Fu, and iShares Russell 2000 Growth ETF. iShares Russell 2000 ETF owns 0.6 million shares of the company’s stock, all valued at over $2.03 million. The company sold 28084.0 shares recently to bring their total holdings to about 1.56% of the shares outstanding. iShares Russell 2000 Growth ETF sold 2584.0 shares to bring its total holdings to over 0.26 million shares at a value of $0.89 million. iShares Russell 2000 Growth ETF now owns shares totaling to 0.68% of the shares outstanding.
Shares of Genprex Inc. (NASDAQ: GNPX) opened at $3.80, unchanged from a prior closing price of $3.80. However, the script later closed the day at $3.93, up 3.42%. The company’s stock has a 5-day price change of -1.26% and 40.86% over the past three months. GNPX shares are trading 1128.13% year to date (YTD), with the 12-month market performance up to 319.87% higher. It has a 12-month low price of $0.23 and touched a high of $7.03 over the same period. Currently, 2.34 million shares have been traded, compared to an average intraday trading volume of 1.79 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 5.57%, 15.70%, and 70.24% respectively.
Institutional ownership of Genprex Inc. (NASDAQ: GNPX) shares accounts for 18.10% of the company’s 35.36M shares outstanding. Mutual fund holders own 4.67%, while other institutional holders and individual stakeholders account for 8.46% and 17.38% respectively.
It has a market capitalization of $156.37M. The earnings-per-share (ttm) stands at -$0.61. Price movements for the stock have been influenced by the stock’s volatility, which stands at 9.28% over the week and 9.37% over the month.
Analysts forecast that Genprex Inc. (GNPX) will achieve an EPS of -$0.15 for the current quarter, -$0.19 for the next quarter and $0.25 for 2021. The lowest estimate earnings-per-share for the quarter is -$0.21 while analysts give the company a high EPS estimate of -$0.09. Comparatively, EPS for the current quarter was -$0.14 a year ago. Earnings per share for the fiscal year are expected to increase by 26.00%, and 158.10% over the next financial year.
Looking at the support for the GNPX, a number of firms have released research notes about the stock. Noble Capital Markets stated their Outperform rating for the stock in a research note on April 29, 2019, with the firm’s price target at $5.